Global Opioid Induced Constipation (OIC) Drugs Market Analysis 2013-2018 and Forecast 2019-2024
December 2018
109
About the Report
About the Report
Snapshot
The global Opioid Induced Constipation (OIC) Drugs market will reach xxx Million USD in 2018 and CAGR xx% 2018-2023. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Opioid Induced Constipation (OIC) Drugs by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
By Drug Type
Lubiprostone
Methyl Naltrexone Bromide
Naldemedine
Alvimopan
Others
By Prescription Type
Generic and Branded Prescribed Drugs
Over The Counter Drugs
Company Coverage (Sales Revenue, Price, Gross Margin, Main Products etc.):
Ironwood Pharmaceuticals Inc
Daiichi Sankyo Co Ltd
Pfizer
Progenics Pharmaceuticals Inc
Shionogi & Co., Ltd
Allergan Plc
Nektar Therapeutics
Purdue Pharma
S.L.A. Pharma AG
Mundipharma International Limited
Ono Pharmaceutical Co., Ltd
Takeda Pharmaceutical Company Limited
Theravance Biopharma Inc
Valeant Pharmaceuticals International
Cosmo Pharmaceuticals SA
Daewoong Pharmaceutical
C.B. Fleet Company
Sucampo Pharmaceuticals
Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
Products
Table of Contents
Table of Contents
Table of Content
1 Industry Overview
1.1 Opioid Induced Constipation (OIC) Drugs Industry
1.1.1 Overview
1.1.2 Development of Opioid Induced Constipation (OIC) Drugs
1.2 Market Segment
1.2.1 Upstream
1.2.2 Downstream
1.3 Cost Analysis
2 Industry Environment
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 Opioid Induced Constipation (OIC) Drugs Market by Type
3.1 By Drug Type
3.1.1 Lubiprostone
3.1.2 Methyl Naltrexone Bromide
3.1.3 Naldemedine
3.1.4 Alvimopan
3.1.5 Others
3.2 By Prescription Type
3.2.1 Generic and Branded Prescribed Drugs
3.2.2 Over The Counter Drugs
3.3 Market Size
3.4 Market Forecast
4 Major Companies List
4.1 Ironwood Pharmaceuticals Inc (Company Profile, Sales Data etc.)
4.2 Daiichi Sankyo Co Ltd (Company Profile, Sales Data etc.)
4.3 Pfizer (Company Profile, Sales Data etc.)
4.4 Progenics Pharmaceuticals Inc (Company Profile, Sales Data etc.)
4.5 Shionogi & Co., Ltd (Company Profile, Sales Data etc.)
4.6 Allergan Plc (Company Profile, Sales Data etc.)
4.7 Nektar Therapeutics (Company Profile, Sales Data etc.)
4.8 Purdue Pharma (Company Profile, Sales Data etc.)
4.9 S.L.A. Pharma AG (Company Profile, Sales Data etc.)
4.10 Mundipharma International Limited (Company Profile, Sales Data etc.)
4.11 Ono Pharmaceutical Co., Ltd (Company Profile, Sales Data etc.)
4.12 Takeda Pharmaceutical Company Limited (Company Profile, Sales Data etc.)
4.13 Theravance Biopharma Inc (Company Profile, Sales Data etc.)
4.14 Valeant Pharmaceuticals International (Company Profile, Sales Data etc.)
4.15 Cosmo Pharmaceuticals SA (Company Profile, Sales Data etc.)
4.16 Daewoong Pharmaceutical (Company Profile, Sales Data etc.)
4.17 C.B. Fleet Company (Company Profile, Sales Data etc.)
4.18 Sucampo Pharmaceuticals (Company Profile, Sales Data etc.)
5 Market Competition
5.1 Company Competition
5.2 Regional Market by Company
6 Market Demand
6.1 Demand Situation
6.1.1 Demand in Hospital Pharmacies
6.1.2 Demand in Retail Pharmacies
6.1.3 Demand in Online Pharmacies
6.2 Regional Demand Comparison
6.3 Demand Forecast
7 Region Operation
7.1 Regional Production
7.2 Regional Market
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
7.3.1.2 by Country (U.S., Canada, Mexico)
7.3.2 Europe
7.3.2.1 Overview
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
7.3.3 Asia-Pacific
7.3.3.1 Overview
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
7.3.4 South America
7.3.4.1 Overview
7.3.4.2 by Country (Brazil, Argentina etc.)
7.3.5 Middle East & Africa
7.3.5.1 Overview
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
7.4 Regional Import & Export
7.5 Regional Forecast
8 Marketing & Price
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
9 Research Conclusion
List of Figure
Figure Opioid Induced Constipation (OIC) Drugs Industry Chain Structure
Figure Global Opioid Induced Constipation (OIC) Drugs Market Growth 2013-2018, by Drug Type, in USD Million
Figure Global Opioid Induced Constipation (OIC) Drugs Market Growth 2013-2018, by Prescription Type, in USD Million
Figure North America Opioid Induced Constipation (OIC) Drugs Market, by Company, in 2018
Figure Europe Opioid Induced Constipation (OIC) Drugs Market Market, by Company, in 2018
Figure Asia-Pacific Opioid Induced Constipation (OIC) Drugs Market Market, by Company, in 2018
Figure South America Opioid Induced Constipation (OIC) Drugs Market Market, by Company, in 2018
Figure Middle East & Africa Opioid Induced Constipation (OIC) Drugs Market Market, by Company, in 2018
Figure North America Opioid Induced Constipation (OIC) Drugs Market Size and Growth 2013-2018, in USD Million
Figure Europe Opioid Induced Constipation (OIC) Drugs Market Size and Growth 2013-2018, in USD Million
Figure Asia-Pacific Opioid Induced Constipation (OIC) Drugs Market Size and Growth 2013-2018, in USD Million
Figure South America Opioid Induced Constipation (OIC) Drugs Market Size and Growth 2013-2018, in USD Million
Figure Middle East & Africa Opioid Induced Constipation (OIC) Drugs Market Size and Growth 2013-2018, in USD Million
Figure Marketing Channels Overview
List of Table
Table Upstream Segment of Opioid Induced Constipation (OIC) Drugs
Table Application Segment of Opioid Induced Constipation (OIC) Drugs
Table Global Opioid Induced Constipation (OIC) Drugs Market 2013-2024, by Application, in USD Million
Table Major Company List of Lubiprostone
Table Major Company List of Methyl Naltrexone Bromide
Table Major Company List of Naldemedine
Table Major Company List of Alvimopan
Table Major Company List of Others
Table Major Company List of Generic and Branded Prescribed Drugs
Table Major Company List of Over The Counter Drugs
Table Global Opioid Induced Constipation (OIC) Drugs Market 2013-2018, by Drug Type, in USD Million
Table Global Opioid Induced Constipation (OIC) Drugs Market 2013-2018, by Prescription Type, in USD Million
Table Global Opioid Induced Constipation (OIC) Drugs Market Forecast 2019-2024, by Drug Type, in USD Million
Table Global Opioid Induced Constipation (OIC) Drugs Market Forecast 2019-2024, by Prescription Type, in USD Million
Table Ironwood Pharmaceuticals Inc Overview List
Table Opioid Induced Constipation (OIC) Drugs Business Operation of Ironwood Pharmaceuticals Inc (Sales Revenue, Cost, Gross Margin)
Table Daiichi Sankyo Co Ltd Overview List
Table Opioid Induced Constipation (OIC) Drugs Business Operation of Daiichi Sankyo Co Ltd (Sales Revenue, Cost, Gross Margin)
Table Pfizer Overview List
Table Opioid Induced Constipation (OIC) Drugs Business Operation of Pfizer (Sales Revenue, Cost, Gross Margin)
Table Progenics Pharmaceuticals Inc Overview List
Table Opioid Induced Constipation (OIC) Drugs Business Operation of Progenics Pharmaceuticals Inc (Sales Revenue, Cost, Gross Margin)
Table Shionogi & Co., Ltd Overview List
Table Opioid Induced Constipation (OIC) Drugs Business Operation of Shionogi & Co., Ltd (Sales Revenue, Cost, Gross Margin)
Table Allergan Plc Overview List
Table Opioid Induced Constipation (OIC) Drugs Business Operation of Allergan Plc (Sales Revenue, Cost, Gross Margin)
Table Nektar Therapeutics Overview List
Table Opioid Induced Constipation (OIC) Drugs Business Operation of Nektar Therapeutics (Sales Revenue, Cost, Gross Margin)
Table Purdue Pharma Overview List
Table Opioid Induced Constipation (OIC) Drugs Business Operation of Purdue Pharma (Sales Revenue, Cost, Gross Margin)
Table S.L.A. Pharma AG Overview List
Table Opioid Induced Constipation (OIC) Drugs Business Operation of S.L.A. Pharma AG (Sales Revenue, Cost, Gross Margin)
Table Mundipharma International Limited Overview List
Table Opioid Induced Constipation (OIC) Drugs Business Operation of Mundipharma International Limited (Sales Revenue, Cost, Gross Margin)
Table Ono Pharmaceutical Co., Ltd Overview List
Table Opioid Induced Constipation (OIC) Drugs Business Operation of Ono Pharmaceutical Co., Ltd (Sales Revenue, Cost, Gross Margin)
Table Takeda Pharmaceutical Company Limited Overview List
Table Opioid Induced Constipation (OIC) Drugs Business Operation of Takeda Pharmaceutical Company Limited (Sales Revenue, Cost, Gross Margin)
Table Theravance Biopharma Inc Overview List
Table Opioid Induced Constipation (OIC) Drugs Business Operation of Theravance Biopharma Inc (Sales Revenue, Cost, Gross Margin)
Table Valeant Pharmaceuticals International Overview List
Table Opioid Induced Constipation (OIC) Drugs Business Operation of Valeant Pharmaceuticals International (Sales Revenue, Cost, Gross Margin)
Table Cosmo Pharmaceuticals SA Overview List
Table Opioid Induced Constipation (OIC) Drugs Business Operation of Cosmo Pharmaceuticals SA (Sales Revenue, Cost, Gross Margin)
Table Daewoong Pharmaceutical Overview List
Table Opioid Induced Constipation (OIC) Drugs Business Operation of Daewoong Pharmaceutical (Sales Revenue, Cost, Gross Margin)
Table C.B. Fleet Company Overview List
Table Opioid Induced Constipation (OIC) Drugs Business Operation of C.B. Fleet Company (Sales Revenue, Cost, Gross Margin)
Table Sucampo Pharmaceuticals Overview List
Table Opioid Induced Constipation (OIC) Drugs Business Operation of Sucampo Pharmaceuticals (Sales Revenue, Cost, Gross Margin)
Table Global Opioid Induced Constipation (OIC) Drugs Sales Revenue 2013-2018, by Company, in USD Million
Table Global Opioid Induced Constipation (OIC) Drugs Sales Revenue Share, by Company, in USD Million
Table Opioid Induced Constipation (OIC) Drugs Demand in Hospital Pharmacies, 2013-2018, in USD Million
Table Major Consumers in Hospital Pharmacies
Table Opioid Induced Constipation (OIC) Drugs Demand in Retail Pharmacies, 2013-2018, in USD Million
Table Major Consumers in Retail Pharmacies
Table Opioid Induced Constipation (OIC) Drugs Demand in Online Pharmacies, 2013-2018, in USD Million
Table Major Consumers in Online Pharmacies
Table Regional Demand Comparison List
Table Major Application in Different Regions
Table Opioid Induced Constipation (OIC) Drugs Demand Forecast 2019-2024, by Application, in USD Million
Table Opioid Induced Constipation (OIC) Drugs Production 2013-2018, by Region, in USD Million
Table Global Opioid Induced Constipation (OIC) Drugs Market 2013-2018, by Region, in USD Million
Table Global Opioid Induced Constipation (OIC) Drugs Market Share 2013-2018, by Region, in USD Million
Table North America Opioid Induced Constipation (OIC) Drugs Market Size 2013-2018, by Country, in USD Million
Table Europe Opioid Induced Constipation (OIC) Drugs Market Size 2013-2018, by Country, in USD Million
Table Asia-Pacific Opioid Induced Constipation (OIC) Drugs Market Size 2013-2018, by Country, in USD Million
Table South America Opioid Induced Constipation (OIC) Drugs Market Size 2013-2018, by Country, in USD Million
Table Middle East & Africa Opioid Induced Constipation (OIC) Drugs Market Size 2013-2018, by Country, in USD Million
Table Opioid Induced Constipation (OIC) Drugs Market Forecast 2019-2024, by Region, in USD Million
Table Price Factors List
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.